Library
a-PHP
alpha-Pyrrolidinohexiophenone (also known as PV-7, alpha-PHP, A-PHP, and α-PHP) is a lesser-known novel stimulant substance of the cathinone class. It is structurally related to MDPV and is one of the successors to the designer drug cathinone analog α-PVP.
Also known as: Pv-7, Α-Pyrrolidinohexiophenone, α-Pyrrolidinohexanophenone, 2-(pyrrolidin-1-yl)-1-(phenyl)hexan-1-one
Classification
- Chemical: Cathinone
- Psychoactive: Stimulant
- Tag: Habit-Forming
- Tag: Pyrrolidinophenone
- Tag: Research-Chemical
- Tag: Synthetic cathinone
- Tag: substituted pyrrolidine
- Tag: Tentative
Effects
- Increased Energyalertness
- Decreased Need For Sleep
- Decreased Appetite
- Weight Loss
- Sweating
- Distrubed Sleep Patterns
- Euphoria
- Increased Sociability
- Mood Lift
- Excessive Talking
- Agressiveness
- Moodiness
- Increased Sexuality
- Visual And Audiotory Hallucinations Itchiness
- Auditory Hallucination
- Auditory Distortion
- Vibrating Vision
- Dehydration
Routes of Administration
Oral
Dosage
- Common: 10-20 mg
- Light: 5-10 mg
- Strong: 20-40 mg
- Threshold: 3–5 mg
- Heavy: 50+ mg
Duration
- Onset: 0-0.3 h
- Peak: 1-2.5 h
- Offset: 1-5 h
- After Effects: 1-48 h
- Total Duration: 2.5-5 h
Insufflated
Dosage
- Threshold: 0.5–1 mg
- Common: 5-15 mg
- Light: 1-5 mg
- Strong: 15-25 mg
- Heavy: 25+ mg
Duration
- Onset: 0.02-0.05 h
- Peak: 0.3-0.8 h
- Offset: 0.5-1.5 h
- After Effects: 6-12 h
- Total Duration: 2-5 h
Smoked
Dosage
- Threshold: 1 mg
- Common: 5-10 mg
- Light: 2-5 mg
- Strong: 10-20 mg
Duration
- Onset: 0-0.1 h
- Peak: 0.5-1.5 h
- Offset: 1-4 h
- After Effects: 1-8 h
Vaporized
Dosage
- Heavy: 30+ mg
- Light: 2–8 mg
- Common: 8–20 mg
- Strong: 20–30 mg
- Threshold: 1–2 mg
Duration
- Onset: 0.01-0.02 h
- Peak: 0.1-0.5 h
- Offset: 0.5-2 h
- After Effects: 6-12 h
- Total Duration: 1-3 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
